Altaf Arshad, Pasha Safdar Kamal
World Health Organization.
World Health Organization (WHO), Pakistan.
J Pak Med Assoc. 2020 Dec;70(12(B)):2454-2456. doi: 10.47391/JPMA.384.
The World Health Organisation (WHO) has set an ambitious target to eliminate hepatitis C virus (HCV) by 2030. Pakistan is one of the focused countries because of the high prevalence of HCV. The prices of direct-acting antiviral drugs(DAA)have significantly reduced to between 11-25 dollars for a month's treatment. To achieve the 2030 elimination target, Pakistan has to provide treatment to one million HCV-infected patients every year, beginning from 2018. This short report highlights a key barrier to achieve this target,i.e. the unsafe practices by regulated and unregulated healthcare delivery system comprising trained and untrained healthcare providers who can continue to churn out new patients with their unsafe healthcare practices and increase the possibility of reinfection in those who have been treated. Only the government has the power and authority to regulate and control the healthcare delivery system. Elimination of Hepatitis in Pakistan will remain a distant dream unless the healthcare delivery system is tamed.
世界卫生组织（WHO）设定了到2030年消除丙型肝炎病毒（HCV）的宏伟目标。由于HCV的高流行率，巴基斯坦是重点关注国家之一。直接作用抗病毒药物（DAA）的价格已大幅降低至每月治疗费用在11至25美元之间。为实现2030年消除目标，巴基斯坦必须从2018年开始，每年为100万HCV感染患者提供治疗。本简短报告强调了实现这一目标的一个关键障碍，即包括经过培训和未经培训的医疗服务提供者在内的受监管和不受监管的医疗服务体系存在不安全做法，这些医疗服务提供者可能会因其不安全的医疗行为不断产生新的患者，并增加已接受治疗者再次感染的可能性。只有政府有权力和权威来规范和控制医疗服务体系。除非医疗服务体系得到规范，否则在巴基斯坦消除肝炎仍将是一个遥不可及的梦想。
